⚕ GalenOps field
←

701-1130

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2014-02-15

AEs
8
Serious
0
Dropout signal
–

Adverse events

mild assessed

Mild EYE ALLERGY — outcome: RECOVERED/RESOLVED; onset 2014-05-09 (study day 84.0); relationship: NONE

mild assessed

Mild EYE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed

Mild EYE SWELLING — outcome: RECOVERED/RESOLVED; onset 2014-05-09 (study day 84.0); relationship: NONE

mild assessed

Mild NASAL CONGESTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed

Mild PYREXIA — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

mild assessed

Mild URINARY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

mild assessed

Mild URINARY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

Data queries

No data queries.